The utility of point of care testing of procalcitonin in paediatric acute assessment

Munro, Alasdair P.S., Hungwe, Charles, Patel, Pratisksha, Ward, Nick, Struthers, Simon and Saeed, Kordo (2022) The utility of point of care testing of procalcitonin in paediatric acute assessment. Infezioni in Medicina, 30 (4), 587-592. (doi:10.53854/liim-3004-14).

Abstract

Objective: febrile illnesses are a common cause of presentation in acute pediatrics, with biomarkers fre-quently used to help differentiate mild infections from serious bacterial infections (SBI). We aimed to see if a point of care test for procalcitonin could help to reduce antibiotic use and avoid unnecessary admission. 

Patients and Methods: a point of care procalcitonin ma-chine which produces results within 20 minutes was in-troduced to two pediatric assessment units across both sites of a secondary-care hospital trust, alongside guid-ance for when tested would be appropriate. We performed a prospective, observational, pilot service eval-uation, of all children tested during the study period of November 2018 to March 2019. We collected data at the time of testing, including the indication for testing and plan prior to testing, then retrospectively collected outcome data for children tested including diagnosis, treatment and whether the child was admitted to hospital. 

Results: 68 tests were performed over 5 months. There are differing denominators due to missing data. Children were predominantly male (40/68, 58.8%) and pre-school age (median age 2.9y, Q1-Q3 1.3-6.7). Severity of illness was low, with 7/54 (11.5%) triggering sepsis tools. The primary indication for testing was febrile illness with no source of infection and some concerning features (31/59, 52.5%). Following testing, 35/67 (52.5%) of patients were admitted and 31/67 (47.1%) had IV antibiotics. A low procalcitonin (<0.5 ng/L) was observed in 46/67 (69.1%) of patients, however 21/46 (45.7%) of these children were admitted and 16/46 (34.8%) were given IV antibi-otics. Procalcitonin performed poorly at detecting SBIs in this cohort (result >0.5 ng/L for 1/5 SBIs). 

Conclusion: there was no clear impact of point of care procalcitonin on admission or antibiotic prescribing in this small pilot study. Clinicians often tested for rea-sons outside the recommended scenarios and often treated “low risk” patients, as determined by low pro-calcitonin, with antibiotics. These effects may be due to low familiarity with procalcitonin as a biomarker.

This record has no associated files available for download.

Contributors

Author: Alasdair P.S. Munro

Author: Kordo Saeed

Download statistics